I A R Kuijlaars1,2, M A Timmer1,2,3, P de Kleijn1,3, M F Pisters2,3,4, K Fischer1. 1. Van Creveldkliniek, University Medical Center Utrecht, Utrecht, The Netherlands. 2. Physical Therapy Sciences, Program in Clinical Health Sciences, University Medical Center Utrecht, Utrecht, The Netherlands. 3. Physical Therapy Research, Department of Rehabilitation, Physiotherapy Science & Sport, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands. 4. Center for Physical Therapy Research and Innovation in Primary Care, Leidsche Rijn Julius Health Care Centers, Utrecht, The Netherlands.
Abstract
INTRODUCTION: Joint bleeds in patients with haemophilia may result in haemophilic arthropathy. Monitoring joint health is essential for identifying early signs of deterioration and allows timely adjustment of treatment. AIM: The aim was to describe changes in joint health over 5-10 years follow-up and identify factors associated with joint health deterioration in patients with haemophilia. METHODS: A post hoc analysis was performed from previous cohort studies in patients with moderate/severe haemophilia, ≥16 years. Joint health of ankles, knees and elbows was measured with the Haemophilia Joint Health Score (HJHS) from 2006-2008 (T0) to 2011-2016 (T1). Analyses were performed on patient level (ΔHJHS-total) and joint level (ΔHJHS-joint). Deterioration was defined as ΔHJHS-total ≥4 and ΔHJHS-joint ≥2. RESULTS: Sixty-two patients (median age 25, 73% severe haemophilia, median [interquartile range] 0.0 [0.0;2.0] joint bleeds between T0 to T1) were included. After median 8 years, HJHS-total deteriorated in 37% and HJHS-joint in 17%. Ankle joints (31%) showed deterioration more often than elbows (19%) and knees (3%). Deterioration of HJHS-total was only associated with severe haemophilia. Deterioration of HJHS-joint was weakly associated with a lower HJHS at baseline and more self-reported limitations in activities, and strongly with more joint bleeds between T0 and T1 and presence of synovitis. CONCLUSION: In 37% of patients with moderate/severe haemophilia and low joint bleeding rates, joint health deteriorated over 5-10 years. Ankle and elbow joints showed deterioration most frequently. Factors found in this study help to identify which joints need frequent monitoring in patients with haemophilia with access to early prophylaxis.
INTRODUCTION: Joint bleeds in patients with haemophilia may result in haemophilic arthropathy. Monitoring joint health is essential for identifying early signs of deterioration and allows timely adjustment of treatment. AIM: The aim was to describe changes in joint health over 5-10 years follow-up and identify factors associated with joint health deterioration in patients with haemophilia. METHODS: A post hoc analysis was performed from previous cohort studies in patients with moderate/severe haemophilia, ≥16 years. Joint health of ankles, knees and elbows was measured with the Haemophilia Joint Health Score (HJHS) from 2006-2008 (T0) to 2011-2016 (T1). Analyses were performed on patient level (ΔHJHS-total) and joint level (ΔHJHS-joint). Deterioration was defined as ΔHJHS-total ≥4 and ΔHJHS-joint ≥2. RESULTS: Sixty-two patients (median age 25, 73% severe haemophilia, median [interquartile range] 0.0 [0.0;2.0] joint bleeds between T0 to T1) were included. After median 8 years, HJHS-total deteriorated in 37% and HJHS-joint in 17%. Ankle joints (31%) showed deterioration more often than elbows (19%) and knees (3%). Deterioration of HJHS-total was only associated with severe haemophilia. Deterioration of HJHS-joint was weakly associated with a lower HJHS at baseline and more self-reported limitations in activities, and strongly with more joint bleeds between T0 and T1 and presence of synovitis. CONCLUSION: In 37% of patients with moderate/severe haemophilia and low joint bleeding rates, joint health deteriorated over 5-10 years. Ankle and elbow joints showed deterioration most frequently. Factors found in this study help to identify which joints need frequent monitoring in patients with haemophilia with access to early prophylaxis.
Authors: Jorge E Machado-Alba; Laura A Chica-Quintero; Manuel E Machado-Duque; Andrés Gaviria-Mendoza; Juan David Wilches-Gutierrez; Diana Rocio Arias-Osorio Journal: Clin Med Insights Blood Disord Date: 2020-10-06
Authors: Richard A Wilkins; David Stephensen; Heidi Siddle; Martin J Scott; Hua Xiang; Elizabeth Horn; Ben Palmer; Graham J Chapman; Michael Richards; Rebecca Walwyn; Anthony Redmond Journal: BMJ Open Date: 2022-01-12 Impact factor: 2.692
Authors: Jean St-Louis; Audrey Abad; Sharon Funk; Merlyn Tilak; Stephen Classey; Nichan Zourikian; Paul McLaughlin; Sébastien Lobet; Grace Hernandez; Stacie Akins; Anna J Wells; Marilyn Manco-Johnson; Judy John; Steve Austin; Pratima Chowdhary; Cedric Hermans; Diane Nugent; Nihal Bakeer; Sarah Mangles; Pamela Hilliard; Victor S Blanchette; Brian M Feldman Journal: Res Pract Thromb Haemost Date: 2022-03-25
Authors: Matteo Nicola Dario Di Minno; Mariasanta Napolitano; Anna Chiara Giuffrida; Erminia Baldacci; Christian Carulli; Elena Boccalandro; Clarissa Bruno; Eleonora Forneris; Irene Ricca; Walter Passeri; Marco Martinelli; Gianna Franca Rivolta; Luigi Piero Solimeno; Carlo Martinoli; Angiola Rocino; Gianluigi Pasta Journal: Br J Haematol Date: 2021-12-19 Impact factor: 8.615
Authors: Isolde A R Kuijlaars; Janjaap van der Net; Brian M Feldman; Magnus Aspdahl; Melanie Bladen; Wypke de Boer; Rubén Cuesta-Barriuso; Ruth E D Matlary; Sharon M Funk; Pamela Hilliard; Judy A John; Christine L Kempton; Piet de Kleijn; Marilyn Manco-Johnson; Pia Petrini; Pradeep Poonnoose; Jean St-Louis; Sylvia Thomas; Merel A Timmer; Sonata Saulyte Trakymiene; Leo van Vlimmeren; Kathelijn Fischer Journal: Haemophilia Date: 2020-10-15 Impact factor: 4.287